Prof John Thompson speaks with ecancer at the EADO 2018 congress in Barcelona on whether we still need surgery to treat advanced melanoma.
Prof Thompson believes that, despite recent trials showing no advantage to a completion lymph node dissection, there are still occasions where sentinel node positive patients could require surgery.
He explains that for patients with a metastatic disease such as isolated systemic metastasis similar results or better can be achieved through surgery.
He also outlines that for patients with macroscopic involvement the 10 year survival rate is around 45% with drug therapies not yet having 5 year survival results.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.